Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07387718 · ClinicalTrials.gov registry record · NA
AIR Support: Artificially Intelligent Robot (AIR) Support for Pediatric Asthma Education
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT07387718: Completed NA study, sponsored by University of Miami.
NCT07387718 is a NA study that has completed, run by University of Miami. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07387718, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this prevention study is to evaluate the design and usability of a newly developed asthma education protocol with the Human Support Robot (HSR) for children with asthma.
Primary Outcome
Feasibility will be assessed by measuring the enrollment rate for the study involving the Human Support Robot. Enrollment rate will be calculated as the number of participants enrolled divided by the number of eligible participants approached, expressed as a percentage. Higher percentages indicate greater feasibility of implementation.
Interventions
- BEHAVIORAL Standard Asthma Education
- BEHAVIORAL Artificially Intelligent Robot (AIR) Support Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2026-06-17 |
| Phase | NA |
What the finished NCT07387718 record still lists
NCT07387718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Asthma Education is the first listed.
NCT07387718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07387718 about?
NCT07387718 is a clinical study titled "AIR Support: Artificially Intelligent Robot (AIR) Support for Pediatric Asthma Education". The purpose of this prevention study is to evaluate the design and usability of a newly developed asthma education protocol with the Human Support Robot (HSR) for children with asthma.
What is the current status of trial NCT07387718?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2026-02-10. Estimated completion is 2026-06-17.
What interventions are being tested in trial NCT07387718?
The interventions under investigation include: Standard Asthma Education (BEHAVIORAL), Artificially Intelligent Robot (AIR) Support Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07387718?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07387718's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI